Description
Tirzepatide 40mg Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide commonly utilized in laboratory research involving metabolic regulation, glucose signaling pathways, incretin receptor activity, appetite regulation mechanisms, and energy balance studies. This compound is supplied as a lyophilized powder and is intended strictly for laboratory and analytical research applications.
Product Specifications
- Compound: Tirzepatide
- Quantity: 40mg
- Appearance: Lyophilized Powder
- Grade: Research Grade
- Packaging: Sealed Sterile Vial
- Intended Use: Laboratory Research Only
Batch Documentation
- COA Type: Manufacturer Certificate of Analysis
- Purity: 99.2%
- Batch Number: TRD-26031301
- Manufacturing Date: Mar. 13, 2026
- Retest Date: Mar. 12, 2028
View the manufacturer Certificate of Analysis (COA) in the product image gallery above.
Research Applications
Tirzepatide is commonly utilized in laboratory studies involving incretin receptor signaling, glucose homeostasis, metabolic regulation, energy expenditure, peptide-receptor interactions, and endocrine signaling pathways. This compound is intended exclusively for scientific and analytical use.
Research Use Only
This product is not intended for human consumption, medical use, therapeutic application, or diagnostic procedures. By purchasing this product, the customer acknowledges they are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.